AlveoliX has a new Business Developer, Léa Todeschini

We are very excited to welcome Léa Todeschini as Business Developer in our team! Léa will be responsible for the growth and development of new business while maintaining customer relationships. We are looking forward to grow and further develop our company together with Léa. If you happen to be near our office, stop by and

More

Publication released in Annual Review

In this new work by Olivier Guenat and Thomas Geiser together with Francois Berthiaume, the possibilities of extracting clinically relevant tissue-level information from Organ on Chip devices are set into perspective. Check this enlightening work in “Clinically Relevant Tissue Scale Responses as New Readouts from Organs-on-a-Chip for Precision Medicine”. Learn more

More

AlveoliX receives the Innosuisse Certification

After having completed the phase of Core Coaching, we have been successfully certified as a company “ready for sustainable growth” by Innosuisse, The Swiss Innovation Agency. We are excited about the new growth phase ahead of us.

More

LOC platforms for inhalation assays

AlveoliX  innovative contribution for lung-on-chip based inhalation assays has been published in “Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipeline” in collaboration with the Israel Institute of Technology, ARTORG Center and Helmholtz Institute for Pharmaceutical Research Saarland. Learn more

More

Meet Alveolix at the SITEM Insel open doors day

The Swiss Institute for Translation and Entrepreneurship in Medicine opens its doors to the public on August 30th to share the spirit of innovation and translational medicine. Join AlveoliX and all new units at SITEM, who will be exposing their cutting-edge technology to make patients life better.

More

AlveoliX’s Board appoints two new CEOs

In the course of this continuous growth, the Board of Directors has decided to further strengthen the positive momentum with a concentrated charge of expertise. Dr. Janick Stucki, AlveoliX’s Chief Technical Officer, and Dr. Nina Hobi, AlveoliX’s Chief Scientific Officer, have been appointed as the company’s new Co-CEOs. Stucki and Hobi succeed Prof. Olivier Guenat,

More

AlveoliX receives Eurostars grant

EUROSTARS is a joint initiative co-funded from the national budgets of 36 Eurostars and by the European Union through Horizon 2020. In the 2014-2020 period, the program has a total public budget of €1.14 billion.

More